RNA Analysis Market worth 3.62 billion USD by 2021
However, lack of skilled professionals in the transcriptomics field and lack of efficient bioinformatics and data analysis tools to analyse enormous data generated from the high-throughput sequencing technologies expected to restrain the growth of this market to a certain extent.
Get Comprehensive Report @ http://www.marketdataforecast.com/market-reports/rna-analysis-market-4541/
RNA Analysis Market segmentation by end user, type and application. By end user the market is segmented into Academic Research & Government Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Diagnostic Centres. By type the market is segmented into Microarrays, Polymerase Chain Reaction (PCR), Sequencing Technologies, and RNAI Gene Silencing. Microarrays are further sub-segmented into Reagents, Instruments and Software. Polymerase Chain Reaction (PCR) is further sub-segmented into Reagents, Instruments and Software. Sequencing Technologies are further sub-segmented into Sanger Sequencing (Reagents, Instruments and Software), and Next Generation Sequencing (NGS) (Reagents, Instruments and Software). RNAI Gene Silencing is further sub-segmented into Reagents, Instruments and Software. By application the market is segmented into Clinical Diagnosis, Drug Discovery, and Toxic genomics.
Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/rna-analysis-market-4541/request-sample
RNA Analysis Market geographical segmentation by North America, Europe, Latin America, Asia Pacific, and Middle East and Africa. North America accounts for the largest share of the market. But still, in the forecast period, emerging economies like Asia-Pacific (Japan, China, and India) and Latin America are anticipated to form new revenue-generating pockets for the market players. Economic developments and increasing government funding to support new product developments are the major factors fuelling the growth of market in these regions.
The major RNA Analysis Market leaders are Illumina Inc. (U.S.), Qiagen N.V. (Germany), Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), and Thermofisher Scientific Inc. (U.S.).
1) End User
Inquire before buying @ http://www.marketdataforecast.com/market-reports/rna-analysis-market-4541/inquire
Scope of the Report:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• Segment-level analysis in terms of end user, type and application along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
• Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
For more information, kindly visit, www.marketdataforecast.com
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
531/MIG-II, Rd Number 1, Kukatpally Housing Board Colony, Kukatpally, Hyderabad, Telangana 500072.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Analysis Market worth 3.62 billion USD by 2021 here
News-ID: 813398 • Views: 283
More Releases from Market Data Forecast
Veterinary Vaccines market value is estimated to grow at a CAGR of 5.5% to incre …
Overview: Veterinary Vaccines Market has seen significant growth over the past few years, due to alarm of imminent epidemics that have led to substantial losses, particularly in poultry segment. View sample and decide: https://www.marketdataforecast.com/market-reports/veterinary-vaccines-market-75/customize-report Market views: Global Veterinary Vaccines market value is estimated to grow at a CAGR of 5.5% to increase to reach a market value to USD 8.46 Billion by 2023. Drivers and restraints: Veterinary Vaccine market has displayed a noteworthy growth in recent years which
Protein Labelling Market Global Growth, Trends, And Forecast To 2024
Recent developments: Proteins are the biggest and most essential biomolecules in a living life form, as they are imperative to the working of a creature. When they are shaped inside a cell, proteins associate with different biomolecules and do jobs to keep the cell alive. Merck's FITC labeling kit gives intends to rapidly and just mark antibodies or different proteins with fluorescein. Coordinate marking of the essential immune response disposes of the
Agricultural biotechnology market– Dupont opened its integrated science and bi …
Recent Developments Du Pont is a science and technology company. This company introduce agriculture products, containing the soybean seed and hybrid corn varients mainly under the brand named Pioneer, canola, sorghum, sunflower, wheat, and rice seeds; silage inoculants, and insect, weed, disease control products, DuPont introduced its first integrated science and biotechnology center, the DuPont Knowledge Center (DKC) in Hyderabad, Telangana state, in 2008. It is a 20-acre campus with a recent
The endovenous ablation segment is expected to command the major share of the Eu …
Overview The Europe Varicose Vein Treatment Market was worth USD 95.4 million in 2018 and estimated to be growing at a CAGR of 6.3%, to reach USD 129.49 million by 2023. The varicose vein treatment market is mainly driven by the rising cases of varicose veins. This condition of enlarged veins appears mostly in feet and legs. It can be caused by pregnancy, hormonal changes, genetic disorders and high blood pressure. View a
More Releases for RNA
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
Automated DNA/RNA Isolation System Market Overview Till 2018-2023
Future Market Reports on Global Automated DNA/RNA Isolation System 2018 Research Report presents a professional and complete analysis of on the current Industry situation. The Global report includes Automated DNA/RNA Isolation System Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Automated DNA/RNA Isolation System market players and the future prospects from various angles
RNA Sequencing: Technologies and Analyses of Global Market Trends
"The Latest Research Report RNA Sequencing: Technologies and Global Markets provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate (CAGR) of 14.9%. The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8
Topics Presented this February 2018 at RNA Therapeutics
SMi’s RNA Therapeutics will be bringing a global presence from MHRA, The RNA Institute, MiNA Therapeutics, AstraZeneca R&D, GSK, Sanofi, CureVac and more. With an agenda full of exciting and new approaches, examine the latest developments in delivery systems for RNA Therapeutics, including Exosomes, Nanocomplexes and Platform Delivery Approaches and patenting RNA Therapeutics. www.therapeutics-rna.com/opr Spotlight: Want to learn about exploiting exosomes for therapeutic use in patients with cystic fibrosis? Have questions answered during
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and